Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SRx Health Solutions (SRXH) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for SRx Health Solutions (SRXH) over the last 16 years, with Q2 2025 value amounting to -$16.8 million.

  • SRx Health Solutions' Consolidated Net Income fell 52783.58% to -$16.8 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$21.8 million, marking a year-over-year decrease of 1658.9%. This contributed to the annual value of $4.2 million for FY2024, which is 11841.02% up from last year.
  • According to the latest figures from Q2 2025, SRx Health Solutions' Consolidated Net Income is -$16.8 million, which was down 52783.58% from -$964000.0 recorded in Q1 2025.
  • In the past 5 years, SRx Health Solutions' Consolidated Net Income ranged from a high of $24.8 million in Q2 2021 and a low of -$24.4 million during Q4 2022
  • Its 5-year average for Consolidated Net Income is -$4.7 million, with a median of -$3.8 million in 2023.
  • As far as peak fluctuations go, SRx Health Solutions' Consolidated Net Income soared by 29820.8% in 2021, and later plummeted by 52783.58% in 2025.
  • Over the past 5 years, SRx Health Solutions' Consolidated Net Income (Quarter) stood at -$5.1 million in 2021, then tumbled by 379.28% to -$24.4 million in 2022, then surged by 39.7% to -$14.7 million in 2023, then skyrocketed by 72.89% to -$4.0 million in 2024, then plummeted by 322.45% to -$16.8 million in 2025.
  • Its Consolidated Net Income was -$16.8 million in Q2 2025, compared to -$964000.0 in Q1 2025 and -$4.0 million in Q4 2024.